Tupy (TUPY3) Q2 2024 earnings summary

Executive summary

• Achieved record Adjusted EBITDA of R$395 million in 2Q24, up 19% year-over-year, with margin rising to 14.1% from 11.2%, despite a 5% revenue decline due to market slowdown and lower volumes.

• Operating cash generation reached R$413 million, the highest for a second quarter, driven by cost reductions, operational efficiency, and working capital management.

• Net income fell 71% to R$18 million, mainly due to exchange rate impacts on derivatives and tax bases, despite strong operational performance.

• Strategic acquisitions, cost reductions, and new contracts in Brazilian agriculture, aftermarket, Manufacturing, and Energy & Decarbonization segments contributed to structural gains and are expected to add over R$200 million/year in revenue.

• Significant investments in research, expansion, bioplants, and decarbonization initiatives support future growth.

Financial highlights

• Revenues: R$2.8 billion in 2Q24, down 5% year-over-year; 1H24 revenues R$5.4 billion, down 6.4%.

• Adjusted EBITDA: R$395 million (+19% YoY), margin 14.1% (+290 bps); gross margin up to 19.4% from 16.6% in 2Q23.

• Net income: R$18 million, impacted by R$168 million negative effect from exchange rate hedging and higher financial expenses.

• Operating expenses fell 4% year-over-year to R$240 million; cost of products sold dropped 8%, boosting gross margin.

• Net debt at quarter-end was R$2.4 billion, or 1.84x LTM Adjusted EBITDA; cash and equivalents at R$2.4 billion.

Outlook and guidance

• Domestic heavy vehicle production is recovering, with truck production up 41% YTD, though still below 2021-2022 levels; North America and Europe face declines but some recovery expected in 2025.

• New contracts and expansion projects, including bioplants and engine machining, expected to contribute over R$200 million annually starting 2025.

• Margins expected to stabilize at 14%-15% with potential for further improvement through selective business and cost control.

• Management remains focused on cash flow generation and margin improvement despite market uncertainties.

• Growth opportunities identified in biogas, spare parts, and new product launches.